KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Shares Outstanding (2017 - 2025)

Guardant Health's Shares Outstanding history spans 8 years, with the latest figure at $124.0 million for Q4 2024.

  • For Q4 2024, Shares Outstanding rose 1.94% year-over-year to $124.0 million; the TTM value through Dec 2024 reached $124.0 million, up 1.94%, while the annual FY2024 figure was $124.0 million, 1.94% up from the prior year.
  • Shares Outstanding for Q4 2024 was $124.0 million at Guardant Health, up from $123.2 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $124.0 million in Q4 2024 and bottomed at $94.5 million in Q1 2020.
  • The 5-year median for Shares Outstanding is $102.3 million (2022), against an average of $108.0 million.
  • The largest annual shift saw Shares Outstanding grew 0.78% in 2022 before it increased 18.58% in 2024.
  • A 5-year view of Shares Outstanding shows it stood at $100.2 million in 2020, then grew by 1.55% to $101.8 million in 2021, then rose by 0.84% to $102.6 million in 2022, then rose by 18.53% to $121.6 million in 2023, then increased by 1.94% to $124.0 million in 2024.
  • Per Business Quant, the three most recent readings for GH's Shares Outstanding are $124.0 million (Q4 2024), $123.2 million (Q3 2024), and $123.0 million (Q2 2024).